TUBB6 is used as a prognostic biomarker in many cancers, such as gastric cancer (Bai et al., 2020), ovarian cancer (Li et al., 2017), prostate cancer (Lin et al., 2019) and triple-negative breast cancer (Chung et al., 2017). The gene discussed is TUBB6; the disease is ovarian carcinoma.